Clinical Prediction of Necrotizing Pneumonia in Children With Mycoplasma pneumoniae : A Model Based on Early Response to Therapy
Canadian Respiratory Journal · 2026-01 · 2026 (1)
DOI: 10.1155/carj/3623045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, online erschienen am 04.08.2026. Verfasst von Jia Feng Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Medicine, Children's Hospital, Tianjin University/Tianjin Children's Hospital, Tianjin, China, hardinge.org. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, Pneumonia, Necrotizing. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Health Research, Tianjin Key Medical Discipline Construction.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
This study aimed to identify factors that predict progression to necrotizing pneumonia (NP) in children with Mycoplasma pneumoniae pneumonia (MPP) who fail to respond to initial therapy and to develop a predictive model to support early clinical decision‐making.
Methods
We retrospectively analyzed clinical and laboratory data of children with macrolide‐unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) admitted to Tianjin Children’s Hospital from January 2021 to January 2025. MUMPP was defined as persistent fever (≥ 38.5°C, lasting ≥ 4 h/day) after ≥ 72 h of standardized intravenous macrolide therapy. Patients were classified into an observation group ( n = 106, those who developed NP) and a control group ( n = 130, those who did not). Independent predictors of NP were identified by multivariable logistic regression and incorporated into a nomogram. Model performance was evaluated using ROC analysis, calibration plots, and decision curve analysis.
Results
In multivariable analysis, increased white blood cell (WBC) count (OR = 2.484, 95% CI: 1.406–4.613), longer fever duration (OR = 1.618, 95% CI: 1.217–2.193), pleural effusion (OR = 3.955, 95% CI: 1.664–10.00), and elevated C‐reactive protein (CRP) (OR = 2.152, 95% CI: 1.547–3.074) were independently associated with NP among children with MPP after initial treatment failure. Calibration curves indicated close agreement between predicted and observed risks in both the derivation cohort ( p = 0.588) and the validation cohort ( p = 0.424). The model showed good discrimination, with an AUC of 0.848 (95% CI: 0.789–0.908) in the derivation cohort and 0.889 (95% CI: 0.815–0.963) in the validation cohort. Decision curve analysis suggested net clinical benefit across relevant threshold probabilities.
Conclusion
Among children with MUMPP, higher WBC count, prolonged fever, pleural effusion, and higher CRP identify increased risk of NP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Respiratory Medicine, Children's Hospital, Tianjin University/Tianjin Children's Hospital, Tianjin, China, hardinge.org.
ORCID-Profile: Jia Feng Zheng, Meng Yao Zhang, Bo Wang, Yong Sheng Xu
Förderung
- Tianjin Health Research
- Tianjin Key Medical Discipline Construction
Zitieren
APA
Zheng, J. F., Zhang, M. Y., Dong, H. Q., Wang, B., & Xu, Y. S. (2026). Clinical Prediction of Necrotizing Pneumonia in Children With Mycoplasma pneumoniae : A Model Based on Early Response to Therapy. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/3623045
Vancouver
Zheng JF, Zhang MY, Dong HQ, Wang B, Xu YS. Clinical Prediction of Necrotizing Pneumonia in Children With Mycoplasma pneumoniae : A Model Based on Early Response to Therapy. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/3623045
BibTeX
@article{Zheng2026,
author = {Zheng, Jia Feng and Zhang, Meng Yao and Dong, Han Quan and Wang, Bo and Xu, Yong Sheng},
title = {Clinical Prediction of Necrotizing Pneumonia in Children With Mycoplasma pneumoniae : A Model Based on Early Response to Therapy},
journal = {Canadian Respiratory Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/carj/3623045}
}
EUVIMED